Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Dornfield
    Member
    • Aug 2010
    • 11

    #1

    Clonal amplification/ Kinetic Exclusion parameters

    Reposted from Library Genertation Forum, where I somehow managed to mispost it...

    Newer generation Illumina platforms with patterened flowcells use kinetic exclusion to achieve a high degree of clonal chastity. From what I understand, the amplification method is still bridge, but is driven by isothermal RPA, so there is no need for the chemical denaturation and renaturation steps of old.
    My question is, can anyone comment on the final number of copies of the clonally amplified material within any given cluster? An although it possibly differs from instrument to instrument, what is the feature size of any given patterned location: what the density of the amplified molecule would therefore be?
    Does the signal generated go through a 'photomultiplier' prior to analysis, which I imagine would reduce the need for a strong raw signal, and so would better accommodate a lower level of amplification/ template density during the clonal amplification?

    Thanks for any insight.
  • Dornfield
    Member
    • Aug 2010
    • 11

    #2
    Perhaps I could come at this from a different direction (or invite educated guesses?). I am not actually an Illumina user, so I'm not familiar with the workflow that generates the clusters in the patterned flow cells: how long (minutes) does this step take, or is this a variable dependent on the insert length? Does this length of time give anyone a clue as to how many copies there might be per cluster?

    Thank you for any input.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      If you look at the images in the patent for patterned flowcells you can get some idea of size of the "features". Someone can chime in about the actual time required for the ExAmp part.

      @nucacidhunter has posted a couple of links about ExAmp in this post.
      Last edited by GenoMax; 10-03-2017, 06:18 AM.

      Comment

      • Dornfield
        Member
        • Aug 2010
        • 11

        #4
        Thanks. I had seen that patent before, but not thought to do some very back of the evenlope calculations:

        250nm diameter features means a surface ares of ~49,000nm^2. My rule of thumb for a DNA polymerase is to think of it as being globular (think spherical) and about 5nm in diameter, so ~19nm^2. So, worst case you could have a lawn of DNA polymerase on the surface of the feature of about 2500 DNA polymerases, before steric interactions become really bad. So even if the lawn of P5 and P7 oligos was denser than that, I'm tempted to think that each feature would be hard pressed to cater for more than a couple of thousand template strands before templates start preferentially annealing to each other, and enzymes start fighting for space.

        2500? Which was kind of my ballpark/ gut feel.

        It would still be good to know how long the ExAmp step takes in the real world.
        Last edited by Dornfield; 10-06-2017, 05:11 AM.

        Comment

        • GenoMax
          Senior Member
          • Feb 2008
          • 7142

          #5
          What is described in the patent and what happens in practice is anyone's guess. Much of the process likely remains a trade secret (exact chemical modification used etc).

          It takes about 3 hours to cluster a 8 lane HiSeq 4000 FC on a cBot.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            Today, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 05:39 AM
          0 responses
          11 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, Yesterday, 09:56 AM
          0 responses
          14 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-09-2026, 11:14 AM
          0 responses
          27 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 09-29-2026, 09:51 AM
          0 responses
          77 views
          0 reactions
          Last Post SEQadmin2  
          Working...